TrialBritish journal of cancer2013

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.

S Boeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.